Target- |
Mechanism- |
Active Org.- |
Originator Org. |
Active Indication- |
Inactive Indication |
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date- |
Target- |
Mechanism- |
Active Org.- |
Originator Org. |
Active Indication- |
Inactive Indication |
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date- |
Target |
Mechanism D4 receptor antagonists |
Active Org.- |
Originator Org. |
Active Indication- |
Inactive Indication |
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date- |
Start Date01 Mar 2007 |
Sponsor / Collaborator |
Start Date01 Feb 2007 |
Sponsor / Collaborator |
Start Date01 Jan 2007 |
Sponsor / Collaborator |
Drug(Targets) | Indications | Global Highest Phase |
---|---|---|
99mTc mAb-17OH.82 | Breast Cancer More | Pending |
TKP-1001 ( APP ) | Alzheimer Disease More | Pending |
TKP-1002 ( D4 receptor ) | Schizophrenia More | Pending |
TSARs (Cytogen) | Neoplasms More | Pending |